Tom Fenton moves from local AI concepts to hands-on tools for matching LLMs to hardware, running local chatbots with Ollama and benchmarking AI performance.
Tracking the oral GLP-1 market battle between Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo. (Hase-Hoch-2/iStock/Getty Images Plus) With the recent launches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results